Back
Sarepta Therapeutics Vs. Catalent Industry Stock Comparison
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
130.77
Seasonality Move:
13.16%
Sell
27
CTLT
Catalent
Last Price:
55.90
Seasonality Move:
11.74%
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $127.39. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Catalent (CTLT)
is a Sell
Is Catalent a Buy, Sell or Hold?
- The current Catalent [CTLT] share price is $55.80. The Score for CTLT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- CTLT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
CTLT Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.27 | Sell |
Relative Strength Index (14 RSI): | 59.71 | Buy |
Chaikin Money Flow: | 406475 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119.4 - 128.64) | Buy |
Bollinger Bands (100): | (101.52 - 131.14) | Buy |
CTLT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 43.93 | Sell |
Chaikin Money Flow: | -1344543 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.85 - 56.73) | Sell |
Bollinger Bands (100): | (45.57 - 58.45) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 119.09 | Buy |
20-day SMA: | 123.08 | Buy |
50-day SMA: | 125.91 | Buy |
200-day SMA: | 111.5 | Buy |
8-day EMA: | 121.38 | Buy |
20-day EMA: | 122.28 | Buy |
50-day EMA: | 122.42 | Buy |
200-day EMA: | 115.88 | Buy |
CTLT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.86 | Sell |
20-day SMA: | 56.33 | Sell |
50-day SMA: | 56.73 | Sell |
200-day SMA: | 47.98 | Buy |
8-day EMA: | 55.97 | Sell |
20-day EMA: | 56.17 | Sell |
50-day EMA: | 55.45 | Buy |
200-day EMA: | 51.58 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.72 per share, an increase next quarter of $3.22 per share, an increase this year of $5.19 per share, and an increase next year of $7.23 per share.
Catalent Earnings Growth & CTLT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.46 per share, and an increase next year of $0.93 per share.
Sarepta Therapeutics Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Catalent Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |